Prosecution Insights
Prosecution Insights
8 pending office actions • 7 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (12%) |
| §103 only | 1 (12%) |
| No statute on record | 6 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AEDER, SEAN E | 1 | 56.9% | +19.6% |
| DAHLE, CHUN WU | 1 | 50.1% | +51.8% |
| OUSPENSKI, ILIA I | 1 | 77.6% | +20.3% |
| HAM, JIEUN | 1 | 50.0% | +0.0% |
| METCALF, MATTHEW CURRAN | 1 | 100.0% | +0.0% |
| MIDDLETON, DANAYA L | 1 | 43.5% | +53.4% |
| YOUTCHOM PENDIE, EMMANUEL LED | 1 | 60.0% | +50.0% |
| PATTERSON, SARAH COOPER | 1 | 58.6% | +56.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18456317 | OPTIMIZED Fc VARIANTS | DAHLE, CHUN WU | 16d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18065462 | BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS | MIDDLETON, DANAYA L | 141d overdue |
| 17692755 | IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS | PATTERSON, SARAH COOPER | 46d overdue |
| 18587839 | HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS | AEDER, SEAN E | 16d |
| 18456317 | OPTIMIZED Fc VARIANTS | DAHLE, CHUN WU | 16d |
| 18053325 | BISPECIFIC ANTIBODIES THAT BIND TO B7H3 AND NKG2D | YOUTCHOM PENDIE, EMMANUEL LED | 29d |
| 18452395 | BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS | OUSPENSKI, ILIA I | 46d |
| Art Unit | Apps |
|---|---|
| 1647 | 2 |
| 1642 | 1 |
| 1641 | 1 |
| 1644 | 1 |
| 1643 | 1 |
| 1674 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18587839 | HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS | AEDER, SEAN E | 1642 | Other | Non-Final OA | 16d | Pending | Feb 26, 2024 |
| 18456317 | OPTIMIZED Fc VARIANTS | DAHLE, CHUN WU | 1641 | §101 | Non-Final OA | 16d | Pending | Aug 25, 2023 |
| 18452395 | BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS | OUSPENSKI, ILIA I | 1644 | Other | Non-Final OA | 46d | Pending | Aug 18, 2023 |
| 18300302 | ANTIBODIES THAT BIND PD-L1, PD-L2, AND/OR CD28 | HAM, JIEUN | 1643 | Other | Non-Final OA | 1d overdue | Pending | Apr 13, 2023 |
| 18296591 | LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS | METCALF, MATTHEW CURRAN | 1647 | Other | Non-Final OA | 52d overdue | Pending | Apr 06, 2023 |
| 18065462 | BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS | MIDDLETON, DANAYA L | 1674 | Other | Non-Final OA | 141d overdue | Pending | Dec 13, 2022 |
| 18053325 | BISPECIFIC ANTIBODIES THAT BIND TO B7H3 AND NKG2D | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | §103 | Non-Final OA | 29d | Pending | Nov 07, 2022 |
| 17692755 | IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS | PATTERSON, SARAH COOPER | 1675 | Other | Non-Final OA | 46d overdue | Pending | Mar 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial